| ²é¿´: 2540 | »Ø¸´: 23 | |||
| µ±Ç°Ö÷ÌâÒѾ´æµµ¡£ | |||
| µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû | |||
286293287½ð³æ (СÓÐÃûÆø)
|
[½»Á÷]
Ò©Æ·×¢²áÓÃÓ¢Óï
|
||
|
Ò©Æ·×¢²áÓÃÓ¢Óï ÏÖÔÚ×ö×¢²á×ÊÁϾ³£»áÉæ¼°Ó¢Óï±í´ï£¬ÎªÁËʹÎÒÃÇдע²á×ÊÁÏʱµÄÓ¢Óï¸ü´¿Õý£¬Ï£Íû¸÷λ´ïÈËÄÜ»ý¼«ÓÂÔ¾Ìṩ¾³£Éæ¼°µÄÓ¢Óï±í´ï£¬Ê¹ÎÒÃǵÄ×¢²áˮƽ¸üÉÏÒ»²ãÂ¥¡£ ÎÒÏÈÅ×שÒýÓñ CEP£ºÅ·ÖÞÒ©µäÊÊÓ¦ÐÔÖ¤Êécertificate of suitability to monograph of European Pharmacopoeia¡£ÊÇÅ·ÖÞÒ©µäËùÊÕÔØµÄÔÁÏÒ©µÄÒ»ÖÖÈÏÖ¤³ÌÐò£¬ÓÃÒÔÈ·¶¨ÔÁÏÒ©µÄÖÊÁ¿¿ÉÒÔÓÃÅ·ÖÞÒ©µäµÄ·½·¨¼ÓÒÔ¿ØÖÆ¡£ÕâÒ»³ÌÐòÊÊÓÃÓÚÉú²úµÄºÍÌáÈ¡µÄÓлú»òÎÞ»úÎïÖÊÒÔ¼°·¢½ÍÉú²úµÄ·ÇÖ±½Ó»ùÒò²úÆ·¡£ DMF£ºDrug master FileÃÀ¹úÒ©ÎïÖ÷Îļþµµ°¸¡£ÊÇÖ¸Ìá½»¸øFDAµÄÓÃÓÚÌṩ¹ØÓÚÈËÓÃÒ©Æ·µÄÉú²úÉ豸¡¢¹¤ÒÕ»òÉú²ú¡¢¹¤ÒÕ´¦Àí¡¢°ü×°ºÍ´¢´æÖÐʹÓõÄÎïÁϵÄÏêϸµÄºÍ±£ÃܵÄÐÅÏ¢¡£·ÖΪÎåÖÖÀàÐÍ£º I£º Éú²úµØµã¡¢É豸¡¢²Ù×÷³ÌÐòºÍÈËÔ± II£º ÔÁÏÒ©¡¢ÔÁÏÒ©ÖмäÌå¡¢Éú²úÔÁÏÒ©ºÍÖмäÌåʹÓõÄÎïÁϺÍÒ©Æ· III£º°ü×°²ÄÁÏ IV£º¸³ÐμÁ¡¢É«ËØ¡¢µ÷ζ¼Á¡¢ÏãÁÏ»òÉú²úÕâЩÎïÖÊËùÓõÄÎïÁÏ V£º FDA½ÓÊܵIJο¼ÐÅÏ¢ EDMF£ºEuropean Drug Master FileÅ·ÖÞÒ©ÎïÖ÷Îļþµµ°¸¡£ÊÇָŷÖÞÖÆ¼ÁÉêÇëÖÐÓйØÔÁÏÒ©ÐÅÏ¢µÄÎļþ£¬ÓÖ³ÆÔÁÏÒ©Ö÷Îļþµµ°¸£¨ASMF£©¡£EDMF Ö»ÓÐÔÚÖÆ¼ÁÉêÇëµÄÖ§³ÖϲÅÄÜÌá½»¡£EDMF·ÖΪÁ½²¿·Ö£º 1£® ÉêÇëÈ˲¿·Ö£¨AP£©£º¹©ÖƼÁÉêÇëÈËʹÓõķDZ£ÃÜÐÅÏ¢£» 2. ÏÞÖÆ²¿·Ö£¨RP£©£ºEDMF³ÖÓÐÈËÈÏΪÊDZ£ÃܵÄÐÅÏ¢¡£ EDMFµÄʹÓ÷¶Î§£º 1. ÐÂÔÁÏÒ© 2. ÒÑÖªµÄµ«Å·ÖÞÒ©µä»òÆä³ÉÔ±¹úÒ©µäûÓÐÊÕÔØµÄÔÁÏÒ© 3. Å·ÖÞÒ©µä»ò³ÉÔ±¹úÒ©µäÒÑÊÕÔØµÄÔÁÏÒ© ANDA£ºAbbreviated New Drug Application ÃÀ¹ú¼òÂÔÐÂÒ©ÉêÇë¡£ÊÇFDA¹æ¶¨µÄ·ÂÖÆÒ©ÉêÇë³ÌÐò¡£ Generic£º·ÂÖÆµÄ£¬·ÇÌØÊâµÄ API£ºActive Pharmaceutical Ingredient ÔÁÏÒ© Dossier£ºÎĵµ£¬µµ°¸¡£ TSE£ºTransmitting animal Spongiform Encephalopathy agent ´«²¥ÐÔ¶¯ÎﺣÃà×´ÄÔ²¡Ìå Q7A£ºICH£¨¹ú¼Êе÷»áÒ飩 ÔÁÏÒ©GMP Ö¸ÄÏ¡£²ûÊöÁËÔÁÏÒ©Éú²úÉÌÓ¦×ñѵÄGMPÖ¸µ¼ÔÔò¡£ Start Material£º¼ò³ÆSM£¬ÆðʼÎïÁÏ¡£ÆðʼÎïÁÏͨ³£±êÖ¾×ÅÉú²ú¹ý³ÌµÄ¿ªÊ¼¡£ºÏ³É¹¤ÒÕÔÁÏÒ©µÄÆðʼÎïÁÏÊÇÖ¸¹¹³ÉÔÁÏÒ©Ö÷Òª½á¹¹Æ¬¶ÏµÄÒ»ÖÖÔ²ÄÁÏ¡¢ÖмäÌå»òÕßÔÁÏÒ©£»Ëü¿ÉÒÔÊÇÒ»ÖÖÉÌÆ·£¬Ò²¿ÉÒÔÊÇÄÚ²¿Éú²úµÄÎïÖÊ£»ÆðʼÎïÁÏÒ»°ã¾ßÓÐÃ÷È·µÄÐÔÖʺͽṹ¡£ BPR£ºBritish Pharmacopoeia Reference Ó¢¹úÒ©µä¶ÔÕÕÆ· EPR£ºEuropean Pharmacopoeia Reference Å·ÖÞÒ©µä¶ÔÕÕÆ· COA£ºCertificate Of Analysis ·ÖÎö±¨¸æµ¥ Food Additive£ºÊ³Æ·Ìí¼Ó¼Á¡£FDA ¶ÔʳƷÌí¼Ó¼ÁµÄ¶¨ÒåÊÇÖ¸ÈκÎÒ»ÖÖÎïÖÊ£¬ËüµÄÔ¤ÆÚµÄÓÃ;¿ÉÒÔ»ò±»ÆÚÍû¿ÉÒÔÖ±½Ó»ò¼ä½ÓµØÊ¹ÕâÖÖÎïÖʳÉΪijһʳƷÖеijɷֻòÓ°ÏìʳƷµÄÌØÕ÷¡£GRASÎïÖʼ°ÎÞÉøÒÆ»ò¼«ÉÙÉøÒÆµÄʳƷ½Ó´¥ÐÔÎïÖʳýÍâ¡£ Dietary Supplement£º Òûʳ²¹³ä¼Á¡£ÃÀ¹ú£±£¹£¹£´Äê°ä²¼µÄ¡¶Òûʳ²¹³ä¼Á½¡¿µÓë½ÌÓý·¨¡·£¨£Ä£Ó£È£Å£Á£©ÖУ¬È·Á¢ÁËÒûʳ²¹³ä¼ÁµÄ¶¨Òå¡£Òûʳ²¹³ä¼ÁÊÇÖ¸º¬ÓС°Òûʳ³É·Ö¡±µÄ¿Ú·þ²úÆ·¡£Õâ Щ²úÆ·ÖÐËùº¬Óеġ°Òûʳ³É·Ö¡±°üÀ¨£ºÎ¬ÉúËØ¡¢¿óÉúÎï¡¢²Ý±¾»òÆäËûÖ²Îï¡¢°±»ùËᣬÒÔ¼°Ã¸¡¢Æ÷¹Ù×éÖ¯¡¢ÏÙÌåºÍ´úлÎïÖ®ÀàµÄÎïÖÊ¡£Òûʳ²¹³ä¼ÁÒ²¿ÉÒÔÊÇÝÍÈ¡Îï»òŨ ËõÎ¶øÇÒ¿ÉÒÔÖÆ³ÉƬ¼Á¡¢½ºÄÒ¡¢Èí½ºµÈ¶àÖÖÐÎʽ¡£ [ Last edited by shich68 on 2008-5-6 at 09:37 ] |
» ²ÂÄãϲ»¶
È˹¤ÖÇÄܸ³ÄܾۺÏÎï¼°¸´ºÏ²ÄÁÏÄ£ÐÍÓ¦ÓÃÓëʵ¼ù
ÒѾÓÐ0È˻ظ´
¸÷¹úºÍ¹ú¼Ê×éÖ¯ÏÖÐÐÒ©µä×¢ÉäÓÃË®ÖÊÁ¿±ê×¼
ÒѾÓÐ0È˻ظ´
Ò©ÎïѧÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ237È˻ظ´
ÇóÖúÓÃ΢Æ×Êý¾Ý¿â²éѯ
ÒѾÓÐ0È˻ظ´
¼ÆË㻯ѧÓëÈ˹¤ÖÇÄÜÇý¶¯µÄMOFsÐÔÄÜÔ¤²âÓëɸѡ¼¼Êõ
ÒѾÓÐ0È˻ظ´
ÑÐÈýʵÑéÇóÖ¸µ¼
ÒѾÓÐ0È˻ظ´
½ðÊô²ÄÁ϶à³ß¶È¼ÆËãÄ£Äâ¼¼ÊõÓëÓ¦ÓãºÎ¢¹Û»úÀíµ½ºê¹ÛÐÔÄܵɹ¤×÷
ÒѾÓÐ0È˻ظ´
½Î÷¿Æ¼¼Ê¦·¶´óѧ΢ÉúÎïÌìȻҩÎïÀÏʦ½éÉÜ
ÒѾÓÐ23È˻ظ´
¡¾ÕÐÆ¸¡¿Çå±±£¨¼ÃÄÏ£©ÉúÎï¿Æ¼¼ÕÐÆ¸AIÖÆÒ©Ñз¢¼ÆËãÈ˲Å
ÒѾÓÐ4È˻ظ´
» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)
xppjd
½ð³æ (ÕýʽдÊÖ)
ľ³æÐ¡ÇàÒÂ
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 722.6
- É¢½ð: 39
- ºì»¨: 1
- Ìû×Ó: 928
- ÔÚÏß: 70.2Сʱ
- ³æºÅ: 322472
- ×¢²á: 2007-03-11
- ÐÔ±ð: MM
- רҵ: ÓлúºÏ³É

22Â¥2008-05-30 22:51:47
harrisonzhang
ľ³æ (³õÈëÎÄ̳)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 3159
- Ìû×Ó: 19
- ÔÚÏß: 62.4Сʱ
- ³æºÅ: 353454
- ×¢²á: 2007-04-23
- ÐÔ±ð: GG
- רҵ: Éñ¾ÉúÎïѧ

2Â¥2007-12-12 02:50:11
286293287
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 988.3
- Ìû×Ó: 197
- ÔÚÏß: 17.4Сʱ
- ³æºÅ: 461045
- ×¢²á: 2007-11-18
- ÐÔ±ð: MM
- רҵ: »¯Ñ§
3Â¥2007-12-12 09:54:15
qingerzheng
гæ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 213
- ºì»¨: 1
- Ìû×Ó: 120
- ÔÚÏß: 60.3Сʱ
- ³æºÅ: 288275
- ×¢²á: 2006-10-21
- רҵ: Ò©¼Á
4Â¥2008-01-03 14:09:45














»Ø¸´´ËÂ¥